SlideShare a Scribd company logo
ELECTIVE SINGLE
EMBRYO TRANSFER
WHY, WHEN AND HOW
DR FESEENA KUNJIMOIDEEN
BDS,MCE(LEEDS,UK)
ARMC IVF Kozhikode
Moulana IVF, Perintalmanna
DEFINITION
Elective Single Embryo Transfer is defined as the transfer of only one
embryo when atleast 2 top quality embryos are available ,to avoid the
complications of multiple pregnancy.
(Norian etal,2009)
WHY SET?
• MATERNAL COMPLICATIONS OF MULTIPLE GESTATION
• FETAL AND NEONATAL COMPLICATIONS OF MULTIPLE GESTATION.
• PSYCHOLOGICAL IMPACT
• COST FACTOR
MATERNAL COMPLICATIONS OF MULTIPLE
PREGNANCY
MATERNAL MORTALITY
• Pulmonary edema in association with parenteral beta-mimetics
tocolysis
•Eclampsia
•Excessive blood loss
MATERNAL COMPLICATIONS(CONTD)
MATERNAL MORBIDITY
Hypertension
(10-20% in twins, 25- 60 % in triplets)
Thromboembolism
Preterm labour
Gestational length inversely related to number of fetuses
Anaemia
22 % incidence in multiple when compared to singleton
Vaginal-Uterine haemorrhage
Fluid overload
Pulmonary edema with parental tocolysis
COMPLICATIONS OF MULTIPLE PREGNANCY
Higher chances for CS when compared to single pregnancy
Complications in CS compared to vaginal delivery
 Infections
Haemorrhage
Thromboembolic diseases
Endometritis.
FETAL AND NEONATAL COMPLICATIONS IN
MULTIPLE BIRTHS
• Stillbirths, early and late neonatal mortality, infant mortality higher in
multiple pregnancies.(~ 5times for twins and 10 times for triplets )
• Preterm delivery (54% of twins preterm compared to 9.6 % for
singletons).Generally, gestational age 3 weeks less for every additional
fetus.
• Low birth weight(Average triplet weighed about half of the average
singleton at birth).
Infants born as multiples comprise only 3 % of all live births but they
comprise 13 % of the preterm babies,15 % of the early preterm babies,
21% of the LBW babies and 25% of the VLBW babies (Martin etal)
NEONATAL MORBIDITY ASSOCIATED WITH LBW
• Birth Asphyxia
• Intraventricular haemorrhage (11.4 % more in twins)
• Sepsis (7.6 %)
• Necrotising enterocollitis (9.9%)
• Respiratory distress syndrome(13.8%)
CONGENITAL MALFORMATIONS COMMONLY
ASSOCIATED WITH MULTIPLE GESTATION
• Cardiac defects
• Neural tube and brain defects.
• Facial clefts
• Gastrointestinal and anterior abdominal wall defects
FOETOFOETAL TRANSFUSION SYNDROME
• Occurs in multifoetal pregnancy in which vascular anastomosis
between 2 monochorionic foetuses allow shunting of blood from one
(donor) to the other foetus(recipient), resulting in severe
oligohydramniosis in the donor and polyhydramniosis in the recipient.
• Discordance in size with larger twin in polyhydromniotic sac.
• Mortality is high even with treatment (40-60%)
• High chance of neurologic impact in surviving foetus
PROBLEMS ASSOCIATED WITH MULTIPLE
PREGNANCY(CONTD)
• Handicap incidence rates increased
 3.7 % increase in twins and 8.7 % in triplets
• Cerebral Paresis(CP) increases with plurality of the foetus
• Mental retardation
• Neurologic and visual impairment
• Psychological impacts on children themselves,siblings and parents
EVIDENCES
 Titinen etal 2003,
• e-SET done if on day 2,atleast 2 top quality embryos were available
• Concluded that if applying SET to about 1/3 of total patients ,possible
to half the multiple pregnancy without reducing ongoing pregnancy
rate.
Even if the number of embryos transferred is restricted to 2, twinning
rate can exceed 40 % of pregnancy(Catt J etal)
WHEN
Strandell etal
1.Female patient younger than 35-37 years
2.In 1st
and 2nd
IVF/ICSI cycles
3.Number of top quality embryos available should be 2 or more .
4.Absence of tubal factor infertility
A STRATEGY FOR SELECTING THE BEST EMBRYO
18-19 hours post ICSI:
The pronuclei are examined for
• Symmetry, greater blastocyst development and implantation when
the numbers and alignment of NPB are symmetrical.
• Presence of even number of nucleolar precursor bodies(NPB)
• Number of NPBs in both pronuclei never differ by more than three
• NPBs polarized or nonpolarized in both pronuclei but never polarized
in one pronucleus and not in the other
• The angle from the axis of the pronuclei and the furthest polar body
be less than 50 degree.
STRATEGY (CONTD)
25-26 hours postinsemination or post ICSI:
• Embryos that have already cleaved to the 2 cell stage
• Zygotes that have progressed to nuclear membrane breakdown
42-44 post insemination:
• Number of blastomeres be equal to or greater than 4
• Fragmentation of less than 20%
• No multinucleated blastomeres
66-68 hours post insemination:
• Number of blastomeres be greater or equal to 8
• Fragmentation of less than 20%
• No multinucleated blastomeres
106-108 hours postinsemination:
• The blastocoel cavity be full
• Inner cell mass be numerous and tightly packed
• Trophectodermal cells be numerous and cohesive .
GRADUATED EMBRYO SCORE (GES)
JD FISCH etal
BLASTOCYST TRANSFER
• Facilitates the natural selection of the best embryo.
• Increase implantation rate and reduces multiple birth
• Require good culture conditions in the lab.
• May end up in no ETs
STUDIES ON SINGLE BLASTOCYST
TRANSFER
• Gardner etal conducted a prospective study on a group of 48 selected
patients and concluded that the transfer of a single blastocyst
resulted in an implantation and ongoing pregnancy rate of 60.9 %
with no twins while transfer of 2 blastocysts resulted in implantation
rate of 56%, ongoing pregnancy rate of 76% but with a 47.4 %
incidence of twins.
NONINVASIVE ASSESSMENT OF EMBRYOS
• Microfluorimetry uses conventional biochemical assays.
Blastocysts with high glucose uptake and reduced lactate production
are found to have more viability and implantation potential
(Vanderbergh etal, lane and gardner)
• Measuring preimplantation embryo physiology using self-referencing
probe to measure the movement of ions and molecules between cell
and the surrounding media.(Trimarchi JR etal)
GLOBAL VARIATION IN THE UPTAKE OF SET
• Most countries show a gradual increase in SET cycles
• Sweden is the country performing maximum SET cycles(69.4%)
followed by Finland(49.7%), Belgium (48%), Denmark (32.6%).
• Reasons favouring SET uptake globally
 Access to public funding
 Legislation .
CONCLUSION
• In patients younger than 38 years with atleast 1 top quality embryo, e SET can be
the transfer policy of choice in at least 3 treatment cycles, since the pregnancy
rates obtained in each treatment cycle are comparable to those after DET.( Land
JA etal).
• Fresh SET and a subsequent transfer of a single frozen thawed embryo in failed
cases clearly improves the cumulative pregnancy rate (per oocyte retrieval)
(Martikainen etal)
• Utilization of technological improvements like Time lapse monitoring allows
continuous ,non-invasive embryo monitoring without removing them from
optimal culture conditions.
• Degree of SET performed at a centre is the best indicator of the performance of
that centre
• In the future,SET is going to be more acceptable as both patients and society
realize the risk of multiple pregnancy.
Set presentation artcon 2015

More Related Content

What's hot

Uterine factor in female infertility
Uterine factor in female infertilityUterine factor in female infertility
Uterine factor in female infertility
Santosh Jena
 
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
Lifecare Centre
 
Follicular monitoring
Follicular monitoring Follicular monitoring
Follicular monitoring
Chandni Wadhwani
 
Hospital Based Surgical Procedures IN POST PARTUM HAEMORRHAGE : Dr Sharda Jai...
Hospital Based Surgical Procedures IN POST PARTUM HAEMORRHAGE : Dr Sharda Jai...Hospital Based Surgical Procedures IN POST PARTUM HAEMORRHAGE : Dr Sharda Jai...
Hospital Based Surgical Procedures IN POST PARTUM HAEMORRHAGE : Dr Sharda Jai...
Lifecare Centre
 
Ovarian stimulation
Ovarian stimulation Ovarian stimulation
Ovarian stimulation
Ahmed Elbohoty
 
Organ transplantation.Prof S. Roshdy
Organ transplantation.Prof S. RoshdyOrgan transplantation.Prof S. Roshdy
Organ transplantation.Prof S. Roshdy
Salah Roshdy AHMED
 
Infertility evaluation
Infertility  evaluationInfertility  evaluation
Infertility evaluation
GovtRoyapettahHospit
 
management of ovarian cysts other than endometriomas in infertility
management of ovarian cysts other than endometriomas in infertilitymanagement of ovarian cysts other than endometriomas in infertility
management of ovarian cysts other than endometriomas in infertility
Rupal Shah
 
Basics of tvs color doppler
Basics of tvs color dopplerBasics of tvs color doppler
Basics of tvs color doppler
Poonam Loomba
 
Skin diseases in pregnancy
Skin diseases in pregnancySkin diseases in pregnancy
Skin diseases in pregnancy
Ahmed Elbohoty
 
treatment of female infertility..... by dr .radhakrishnan.....
treatment of female infertility..... by dr .radhakrishnan.....treatment of female infertility..... by dr .radhakrishnan.....
treatment of female infertility..... by dr .radhakrishnan.....
Radhakrishnan Marimuthu
 
Future of IVF : scoping view
Future of IVF : scoping viewFuture of IVF : scoping view
Future of IVF : scoping view
Hesham Al-Inany
 
Reproductive gynaecology
Reproductive gynaecologyReproductive gynaecology
Reproductive gynaecology
Ahmed Elbohoty
 
Hinduja Hospital Webinar on Understanding Undescended Testis
Hinduja Hospital Webinar on Understanding Undescended TestisHinduja Hospital Webinar on Understanding Undescended Testis
Hinduja Hospital Webinar on Understanding Undescended Testis
Hinduja Hospital
 
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
Lifecare Centre
 
Approach to a case of female infertility dr monikha
Approach to a case of female infertility dr monikhaApproach to a case of female infertility dr monikha
Approach to a case of female infertility dr monikha
Monikha Ess Ess
 
Fibroid presentation1
Fibroid presentation1Fibroid presentation1
Fibroid presentation1
DrRokeyaBegum
 
Male infertility
Male infertilityMale infertility
Male infertility
Ahmed Elbohoty
 
Female infertility
Female infertilityFemale infertility
Female infertility
akshaykumar choragi
 
Overview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy LossOverview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy Loss
Dr.Laxmi Agrawal Shrikhande
 

What's hot (20)

Uterine factor in female infertility
Uterine factor in female infertilityUterine factor in female infertility
Uterine factor in female infertility
 
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
 
Follicular monitoring
Follicular monitoring Follicular monitoring
Follicular monitoring
 
Hospital Based Surgical Procedures IN POST PARTUM HAEMORRHAGE : Dr Sharda Jai...
Hospital Based Surgical Procedures IN POST PARTUM HAEMORRHAGE : Dr Sharda Jai...Hospital Based Surgical Procedures IN POST PARTUM HAEMORRHAGE : Dr Sharda Jai...
Hospital Based Surgical Procedures IN POST PARTUM HAEMORRHAGE : Dr Sharda Jai...
 
Ovarian stimulation
Ovarian stimulation Ovarian stimulation
Ovarian stimulation
 
Organ transplantation.Prof S. Roshdy
Organ transplantation.Prof S. RoshdyOrgan transplantation.Prof S. Roshdy
Organ transplantation.Prof S. Roshdy
 
Infertility evaluation
Infertility  evaluationInfertility  evaluation
Infertility evaluation
 
management of ovarian cysts other than endometriomas in infertility
management of ovarian cysts other than endometriomas in infertilitymanagement of ovarian cysts other than endometriomas in infertility
management of ovarian cysts other than endometriomas in infertility
 
Basics of tvs color doppler
Basics of tvs color dopplerBasics of tvs color doppler
Basics of tvs color doppler
 
Skin diseases in pregnancy
Skin diseases in pregnancySkin diseases in pregnancy
Skin diseases in pregnancy
 
treatment of female infertility..... by dr .radhakrishnan.....
treatment of female infertility..... by dr .radhakrishnan.....treatment of female infertility..... by dr .radhakrishnan.....
treatment of female infertility..... by dr .radhakrishnan.....
 
Future of IVF : scoping view
Future of IVF : scoping viewFuture of IVF : scoping view
Future of IVF : scoping view
 
Reproductive gynaecology
Reproductive gynaecologyReproductive gynaecology
Reproductive gynaecology
 
Hinduja Hospital Webinar on Understanding Undescended Testis
Hinduja Hospital Webinar on Understanding Undescended TestisHinduja Hospital Webinar on Understanding Undescended Testis
Hinduja Hospital Webinar on Understanding Undescended Testis
 
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
 
Approach to a case of female infertility dr monikha
Approach to a case of female infertility dr monikhaApproach to a case of female infertility dr monikha
Approach to a case of female infertility dr monikha
 
Fibroid presentation1
Fibroid presentation1Fibroid presentation1
Fibroid presentation1
 
Male infertility
Male infertilityMale infertility
Male infertility
 
Female infertility
Female infertilityFemale infertility
Female infertility
 
Overview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy LossOverview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy Loss
 

Similar to Set presentation artcon 2015

The modern approach in ART today and tomorrow
The modern approach in ART today and tomorrowThe modern approach in ART today and tomorrow
The modern approach in ART today and tomorrow
Yuzko Olexandr
 
Newdevelopment
NewdevelopmentNewdevelopment
Newdevelopment
t7260678
 
Daganasrm2009abstracto268 12564089438001-phpapp02
Daganasrm2009abstracto268 12564089438001-phpapp02Daganasrm2009abstracto268 12564089438001-phpapp02
Daganasrm2009abstracto268 12564089438001-phpapp02
t7260678
 
Daganasrm2009abstracto268 12564089438001-phpapp02 (1)
Daganasrm2009abstracto268 12564089438001-phpapp02 (1)Daganasrm2009abstracto268 12564089438001-phpapp02 (1)
Daganasrm2009abstracto268 12564089438001-phpapp02 (1)
t7260678
 
Multiple Gestation.pptx
Multiple Gestation.pptxMultiple Gestation.pptx
Multiple Gestation.pptx
MDasan1
 
MFG
MFGMFG
Blastocyst transfer
Blastocyst transferBlastocyst transfer
Blastocyst transfer
Antima Rathore
 
Multiple pregnancy after art
Multiple pregnancy after artMultiple pregnancy after art
Multiple pregnancy after art
Dr.Laxmi Agrawal Shrikhande
 
ART Multiple gestation Management.ppt
ART Multiple gestation Management.pptART Multiple gestation Management.ppt
ART Multiple gestation Management.ppt
SriSushmaNagasuri
 
Presentation on D3 versus D5 Embryo Transfer.pptx
Presentation on D3 versus D5 Embryo Transfer.pptxPresentation on D3 versus D5 Embryo Transfer.pptx
Presentation on D3 versus D5 Embryo Transfer.pptx
drshivanisachdev1
 
Multifoetal reduction in Infertility
Multifoetal reduction in InfertilityMultifoetal reduction in Infertility
Multifoetal reduction in Infertility
Sujoy Dasgupta
 
Twins utz
Twins utzTwins utz
Twins utz
maricar chua
 
MULTIPLE PREGNANCY revision 2.pptx
MULTIPLE PREGNANCY revision 2.pptxMULTIPLE PREGNANCY revision 2.pptx
MULTIPLE PREGNANCY revision 2.pptx
MaryamYahya8
 
Blastocyst Culture Benefit and Harms
Blastocyst Culture  Benefit and HarmsBlastocyst Culture  Benefit and Harms
Blastocyst Culture Benefit and Harms
Dr. Jyoti Malik
 
Multiple pregnancy lecture_r_yan
Multiple pregnancy lecture_r_yanMultiple pregnancy lecture_r_yan
Multiple pregnancy lecture_r_yan
Ryan Mulyana
 
Multiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfMultiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdf
SalahRoshdy2
 
Multiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfMultiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdf
SalahRoshdy2
 
Twin pregnancy update hospital segamat
Twin pregnancy update hospital segamatTwin pregnancy update hospital segamat
Twin pregnancy update hospital segamat
Dr Zharifhussein
 
EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT?
EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT? EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT?
EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT?
Rahul Sen
 
Twin, Prof S.Roshdy.ppt
Twin, Prof S.Roshdy.pptTwin, Prof S.Roshdy.ppt
Twin, Prof S.Roshdy.ppt
SalahRoshdy2
 

Similar to Set presentation artcon 2015 (20)

The modern approach in ART today and tomorrow
The modern approach in ART today and tomorrowThe modern approach in ART today and tomorrow
The modern approach in ART today and tomorrow
 
Newdevelopment
NewdevelopmentNewdevelopment
Newdevelopment
 
Daganasrm2009abstracto268 12564089438001-phpapp02
Daganasrm2009abstracto268 12564089438001-phpapp02Daganasrm2009abstracto268 12564089438001-phpapp02
Daganasrm2009abstracto268 12564089438001-phpapp02
 
Daganasrm2009abstracto268 12564089438001-phpapp02 (1)
Daganasrm2009abstracto268 12564089438001-phpapp02 (1)Daganasrm2009abstracto268 12564089438001-phpapp02 (1)
Daganasrm2009abstracto268 12564089438001-phpapp02 (1)
 
Multiple Gestation.pptx
Multiple Gestation.pptxMultiple Gestation.pptx
Multiple Gestation.pptx
 
MFG
MFGMFG
MFG
 
Blastocyst transfer
Blastocyst transferBlastocyst transfer
Blastocyst transfer
 
Multiple pregnancy after art
Multiple pregnancy after artMultiple pregnancy after art
Multiple pregnancy after art
 
ART Multiple gestation Management.ppt
ART Multiple gestation Management.pptART Multiple gestation Management.ppt
ART Multiple gestation Management.ppt
 
Presentation on D3 versus D5 Embryo Transfer.pptx
Presentation on D3 versus D5 Embryo Transfer.pptxPresentation on D3 versus D5 Embryo Transfer.pptx
Presentation on D3 versus D5 Embryo Transfer.pptx
 
Multifoetal reduction in Infertility
Multifoetal reduction in InfertilityMultifoetal reduction in Infertility
Multifoetal reduction in Infertility
 
Twins utz
Twins utzTwins utz
Twins utz
 
MULTIPLE PREGNANCY revision 2.pptx
MULTIPLE PREGNANCY revision 2.pptxMULTIPLE PREGNANCY revision 2.pptx
MULTIPLE PREGNANCY revision 2.pptx
 
Blastocyst Culture Benefit and Harms
Blastocyst Culture  Benefit and HarmsBlastocyst Culture  Benefit and Harms
Blastocyst Culture Benefit and Harms
 
Multiple pregnancy lecture_r_yan
Multiple pregnancy lecture_r_yanMultiple pregnancy lecture_r_yan
Multiple pregnancy lecture_r_yan
 
Multiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfMultiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdf
 
Multiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfMultiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdf
 
Twin pregnancy update hospital segamat
Twin pregnancy update hospital segamatTwin pregnancy update hospital segamat
Twin pregnancy update hospital segamat
 
EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT?
EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT? EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT?
EMBRYO QUALITY ASSESSMENT, WHICH TO SELECT?
 
Twin, Prof S.Roshdy.ppt
Twin, Prof S.Roshdy.pptTwin, Prof S.Roshdy.ppt
Twin, Prof S.Roshdy.ppt
 

Recently uploaded

Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
Dr Nitin Tyagi
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
Golden Helix
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
MuskanShingari
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
KULDEEP VYAS
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
Dr. Deepika's Homeopathy - Gaur City
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
Dr. Dhwani kawedia
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
Gokuldas Hospital
 

Recently uploaded (20)

Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
 

Set presentation artcon 2015

  • 1. ELECTIVE SINGLE EMBRYO TRANSFER WHY, WHEN AND HOW DR FESEENA KUNJIMOIDEEN BDS,MCE(LEEDS,UK) ARMC IVF Kozhikode Moulana IVF, Perintalmanna
  • 2. DEFINITION Elective Single Embryo Transfer is defined as the transfer of only one embryo when atleast 2 top quality embryos are available ,to avoid the complications of multiple pregnancy. (Norian etal,2009)
  • 3. WHY SET? • MATERNAL COMPLICATIONS OF MULTIPLE GESTATION • FETAL AND NEONATAL COMPLICATIONS OF MULTIPLE GESTATION. • PSYCHOLOGICAL IMPACT • COST FACTOR
  • 4. MATERNAL COMPLICATIONS OF MULTIPLE PREGNANCY MATERNAL MORTALITY • Pulmonary edema in association with parenteral beta-mimetics tocolysis •Eclampsia •Excessive blood loss
  • 5. MATERNAL COMPLICATIONS(CONTD) MATERNAL MORBIDITY Hypertension (10-20% in twins, 25- 60 % in triplets) Thromboembolism Preterm labour Gestational length inversely related to number of fetuses Anaemia 22 % incidence in multiple when compared to singleton Vaginal-Uterine haemorrhage Fluid overload Pulmonary edema with parental tocolysis
  • 6. COMPLICATIONS OF MULTIPLE PREGNANCY Higher chances for CS when compared to single pregnancy Complications in CS compared to vaginal delivery  Infections Haemorrhage Thromboembolic diseases Endometritis.
  • 7. FETAL AND NEONATAL COMPLICATIONS IN MULTIPLE BIRTHS • Stillbirths, early and late neonatal mortality, infant mortality higher in multiple pregnancies.(~ 5times for twins and 10 times for triplets ) • Preterm delivery (54% of twins preterm compared to 9.6 % for singletons).Generally, gestational age 3 weeks less for every additional fetus. • Low birth weight(Average triplet weighed about half of the average singleton at birth). Infants born as multiples comprise only 3 % of all live births but they comprise 13 % of the preterm babies,15 % of the early preterm babies, 21% of the LBW babies and 25% of the VLBW babies (Martin etal)
  • 8. NEONATAL MORBIDITY ASSOCIATED WITH LBW • Birth Asphyxia • Intraventricular haemorrhage (11.4 % more in twins) • Sepsis (7.6 %) • Necrotising enterocollitis (9.9%) • Respiratory distress syndrome(13.8%)
  • 9. CONGENITAL MALFORMATIONS COMMONLY ASSOCIATED WITH MULTIPLE GESTATION • Cardiac defects • Neural tube and brain defects. • Facial clefts • Gastrointestinal and anterior abdominal wall defects
  • 10. FOETOFOETAL TRANSFUSION SYNDROME • Occurs in multifoetal pregnancy in which vascular anastomosis between 2 monochorionic foetuses allow shunting of blood from one (donor) to the other foetus(recipient), resulting in severe oligohydramniosis in the donor and polyhydramniosis in the recipient. • Discordance in size with larger twin in polyhydromniotic sac. • Mortality is high even with treatment (40-60%) • High chance of neurologic impact in surviving foetus
  • 11. PROBLEMS ASSOCIATED WITH MULTIPLE PREGNANCY(CONTD) • Handicap incidence rates increased  3.7 % increase in twins and 8.7 % in triplets • Cerebral Paresis(CP) increases with plurality of the foetus • Mental retardation • Neurologic and visual impairment • Psychological impacts on children themselves,siblings and parents
  • 12. EVIDENCES  Titinen etal 2003, • e-SET done if on day 2,atleast 2 top quality embryos were available • Concluded that if applying SET to about 1/3 of total patients ,possible to half the multiple pregnancy without reducing ongoing pregnancy rate. Even if the number of embryos transferred is restricted to 2, twinning rate can exceed 40 % of pregnancy(Catt J etal)
  • 13. WHEN Strandell etal 1.Female patient younger than 35-37 years 2.In 1st and 2nd IVF/ICSI cycles 3.Number of top quality embryos available should be 2 or more . 4.Absence of tubal factor infertility
  • 14.
  • 15. A STRATEGY FOR SELECTING THE BEST EMBRYO 18-19 hours post ICSI: The pronuclei are examined for • Symmetry, greater blastocyst development and implantation when the numbers and alignment of NPB are symmetrical. • Presence of even number of nucleolar precursor bodies(NPB) • Number of NPBs in both pronuclei never differ by more than three • NPBs polarized or nonpolarized in both pronuclei but never polarized in one pronucleus and not in the other • The angle from the axis of the pronuclei and the furthest polar body be less than 50 degree.
  • 16. STRATEGY (CONTD) 25-26 hours postinsemination or post ICSI: • Embryos that have already cleaved to the 2 cell stage • Zygotes that have progressed to nuclear membrane breakdown 42-44 post insemination: • Number of blastomeres be equal to or greater than 4 • Fragmentation of less than 20% • No multinucleated blastomeres
  • 17. 66-68 hours post insemination: • Number of blastomeres be greater or equal to 8 • Fragmentation of less than 20% • No multinucleated blastomeres 106-108 hours postinsemination: • The blastocoel cavity be full • Inner cell mass be numerous and tightly packed • Trophectodermal cells be numerous and cohesive .
  • 18. GRADUATED EMBRYO SCORE (GES) JD FISCH etal
  • 19.
  • 20. BLASTOCYST TRANSFER • Facilitates the natural selection of the best embryo. • Increase implantation rate and reduces multiple birth • Require good culture conditions in the lab. • May end up in no ETs
  • 21. STUDIES ON SINGLE BLASTOCYST TRANSFER • Gardner etal conducted a prospective study on a group of 48 selected patients and concluded that the transfer of a single blastocyst resulted in an implantation and ongoing pregnancy rate of 60.9 % with no twins while transfer of 2 blastocysts resulted in implantation rate of 56%, ongoing pregnancy rate of 76% but with a 47.4 % incidence of twins.
  • 22. NONINVASIVE ASSESSMENT OF EMBRYOS • Microfluorimetry uses conventional biochemical assays. Blastocysts with high glucose uptake and reduced lactate production are found to have more viability and implantation potential (Vanderbergh etal, lane and gardner) • Measuring preimplantation embryo physiology using self-referencing probe to measure the movement of ions and molecules between cell and the surrounding media.(Trimarchi JR etal)
  • 23. GLOBAL VARIATION IN THE UPTAKE OF SET • Most countries show a gradual increase in SET cycles • Sweden is the country performing maximum SET cycles(69.4%) followed by Finland(49.7%), Belgium (48%), Denmark (32.6%). • Reasons favouring SET uptake globally  Access to public funding  Legislation .
  • 24.
  • 25. CONCLUSION • In patients younger than 38 years with atleast 1 top quality embryo, e SET can be the transfer policy of choice in at least 3 treatment cycles, since the pregnancy rates obtained in each treatment cycle are comparable to those after DET.( Land JA etal). • Fresh SET and a subsequent transfer of a single frozen thawed embryo in failed cases clearly improves the cumulative pregnancy rate (per oocyte retrieval) (Martikainen etal) • Utilization of technological improvements like Time lapse monitoring allows continuous ,non-invasive embryo monitoring without removing them from optimal culture conditions. • Degree of SET performed at a centre is the best indicator of the performance of that centre • In the future,SET is going to be more acceptable as both patients and society realize the risk of multiple pregnancy.